Effect of Shorter Dose Interruption in Radioiodine-Refractory Differentiated Thyroid Cancer

Researchers evaluated the impact of dose interruption on survival for lenvatinib vs placebo in patients with progressive differentiated thyroid cancer.

Source: CancerNetwork - March 18, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news